- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05104151
Efficacy of a Nutritive Bar, in Reduction of Weight, Body Fat and Control of Appetite
November 1, 2021 updated by: Uriel Palacios, CES University
Evaluation of the Efficacy of a Nutritive Bar, in Reduction of Weight, Body Fat and Control of Appetite, in Patients With Overweight or Obesity in the City of medellín, 2017
The main objective of the trial is to measure the efficacy of a nutritive bar, in the reduction of weight, body fat and the control of appetite, in patients with overweight and obesity.
It will be a randomized single-blind design conducted in 40 subjects.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Primary objective and outcome: Difference in body fat percentage and summation of the absolute value of 7 body folds
Secondary objectives and outcomes:
- Characterize demographically and clinically the population participating in the research study.
- Determine the differences in body weight between the study groups.
- Determine the median of minutes of appetite onset in each of the groups. Design: The proposed study is a randomized, single-blind, paralell, single center study. Number of subjects: The number of subjects will be 40. At the start of the study, subjects will be randomly assigned to 2 different groups. All participants will have a evaluation with a nutritionist for an anthropometric assessment that includes the measurement of percentage of fat, sum of body folds, weight, height and Body Mass Index. All participants will receive a nutritional intervention providing a caloric deficit of 500 calories, depending on their daily requirements,and they will be prescribed moderate physical activity from 60 to 90 minutes daily. Participants will then be randomly assigned to gruop A: the nutritional bar group or group B: Control. Participants in group A will be instructed to consume the nutritional bar as an integral part of the previously established caloric regimen so as not to increase the number of prescribed calories and will be instructed to consume the product twice a day during the whole study, approximately 2 to 4 hours after breakfast and 2 to 4 hours after lunch, without additions of other foods or beverages, during consumption, may only be accompanied with water. Participants in group B will be instructed to consume a nutritious snack corresponding to the amount of calories provided by the bar, 2 to 4 hours after breakfast and 2 to 4 hours after lunch. The nutritional intervention will be carried out for 8 weeks for both groups, during the forth week and during the eight week of the intervention, a new nutritional assessment will be carried out with the same protocol of the first evaluation, by a nutritionist to all participants.
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Antioquia
-
Medellín, Antioquia, Colombia, 050001
- CES University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 50 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Overweight or obesity (BMI range between 25.0 and 35 kg per m2 and
- Percentage of fat ≥28 for women and ≥20 for men
Exclusion Criteria:
- Pregnant
- People with gastrointestinal, thyroid, renal, hepatic or cardiovascular diseases.
- Diabetics or hypertensive.
- People with eating disorders.
- Use of anti-obesity drugs in the last 4 weeks.
- Use of nutritional or medicinal anti-obesity supplements in the last 4 weeks.
- Celiac Disease.
- Allergies to peanuts, nines, eggs, milk or products derived from milk.
- Vegans.
- Physical or mental disability.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group with nutritional bar
Participants will recieve two nutritional bars per day during eight weeks, and will receive a healthy habits intervention wich includes: nutritional intervention providing a caloric deficit of 500 calories, and a prescription of moderate physical activity from 60 to 90 minutes daily.
|
Protein-based nutritional bar, providing 155 calories per bar
The participants included, will receive a nutritional intervention providing a caloric deficit of 500 calories, depending on their daily requirements, these daily requirements calculated according to the formula BMR (Basic Metabolic Rate).
Also prescription of moderate physical activity from 60 to 90 minutes daily will be made.
|
|
Active Comparator: Group without nutritional bar
Participants will receive a healthy habits intervention wich includes nutritional intervention providing a caloric deficit of 500 calories, and a prescription of moderate physical activity from 60 to 90 minutes daily during eight weeks.
|
The participants included, will receive a nutritional intervention providing a caloric deficit of 500 calories, depending on their daily requirements, these daily requirements calculated according to the formula BMR (Basic Metabolic Rate).
Also prescription of moderate physical activity from 60 to 90 minutes daily will be made.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference in body fat percentage
Time Frame: These measuremen will be made on: day one of study start for each particinat, during the fourth week of each participant of the study and during the eighth (last week) of the study for each participant
|
The difference in changes of corporal body fat will be measured by calculating the percentage of body fat and the summation of the absolute value of 7 body folds.
The percentage of body fat will be determined by using the Siri equation (% Fat = 4.95 / Dc) - 4.50 x 100), the calculation of the body density by the Jackson and Pollock anthropometric equation Dc = 1.10938 - 0.0008267 (sum of three folds) + 0.0000016 (sum of three folds) 2 - 0.0002574 years), the body folds for this outcome will be performed according to the International Society for the Advancement of Cineanthropometry (ISAK) protocol, with the body adipometer Harpenden (In women: Triceps, supraspinal and anterior thigh) (in men: pectoral, abdomen and thigh).
|
These measuremen will be made on: day one of study start for each particinat, during the fourth week of each participant of the study and during the eighth (last week) of the study for each participant
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference in body weight
Time Frame: This measuremen will be made on: day one of study start for each particinat, during the fourth week of each participant of the study and during the eighth (last week) of the study for each participant
|
The subjects will be weighed by means of a balance SECA 813
|
This measuremen will be made on: day one of study start for each particinat, during the fourth week of each participant of the study and during the eighth (last week) of the study for each participant
|
|
Determine the median of minutes of appetite onset in each of the groups.
Time Frame: These levels will be measured over two days over the course of week one of the study for both groups
|
The level of appetite after consumption of the food will be evaluated using an analogue visual scale (AVE).
The AVE for appetite ranges from "0" (least appetite) to 10 (maximum appetite or hunger) and will be printed on sheets that will be delivered to the participants on the day of their nutritional evaluation and also by email, in case the lose Participants will be asked to either consume the product for group A or the isocaloric food recommended by the nutritionist for group B for two moments in the day (mid-morning or second feeding of the day and during the mid-afternoon or the fourth meal of the day), the subjects will be asked to write in the format the time of food intake, then the subjects must complete the EVA appetite scale every half hour for 2 hours.
write by text message to the researchers the time of food consumption, so that they remind participants to fill out the form every 30 minutes.
|
These levels will be measured over two days over the course of week one of the study for both groups
|
|
Difference in summation of the absolute value of 7 body folds
Time Frame: This measuremen will be made on: day one of study start for each particinat, during the fourth week of each participant of the study and during the eighth (last week) of the study for each participant
|
The body folds for this outcome will be performed according to the International Society for the Advancement of Cineanthropometry (ISAK) protocol, with the body adipometer Harpenden, the 7 body folds will be (triceps, biceps, subscapular, abdominal, supraspinal, anterior thigh and middle leg), and then will be made the summation of the absolute value of these 7 body folds
|
This measuremen will be made on: day one of study start for each particinat, during the fourth week of each participant of the study and during the eighth (last week) of the study for each participant
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Uriel Palacios, MD, Professor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 20, 2017
Primary Completion (Actual)
June 13, 2021
Study Completion (Actual)
July 27, 2021
Study Registration Dates
First Submitted
October 21, 2021
First Submitted That Met QC Criteria
November 1, 2021
First Posted (Actual)
November 2, 2021
Study Record Updates
Last Update Posted (Actual)
November 2, 2021
Last Update Submitted That Met QC Criteria
November 1, 2021
Last Verified
October 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 668
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
IPD will not be shared because the privacy of the participants will be guaranteed by not divulging their names in the scientific study process, or publication.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight or Obesity
-
PfizerNot yet recruitingObesity | Overnutrition | Nutrition Disorders | Overweight | Body Weight | Overweight or Obesity | Overweight and/or Obesity | Nutritional and Metabolic DiseasesUnited States
-
National University Health System, SingaporeActive, not recruitingObesity | Overweight and/or Obesity | Overweight or Obese Adults | Overweight , ObesitySingapore
-
Carmen Lucas AbellánUniversidad Católica San Antonio de MurciaCompletedOverweight/Obesity | Overweight or Obese | Overweight or Obese Adults | Obesity and Overweight | Obese SubjectsSpain
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.Recruiting
-
Universidad Católica San Antonio de MurciaEnrolling by invitationObesity | Overweight or ObesitySpain
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Hebei Medical University Third HospitalWestlake UniversityActive, not recruiting
-
Universidad Pablo de OlavideUniversity of SevilleCompletedObesity | Overweight and Obesity | Overweight or ObesitySpain
-
BrightGene New Bio-Medical Technology(Wuxi) Co.Ltd...Recruiting
Clinical Trials on Nutritional bar
-
Superior UniversityActive, not recruitingEnduring Personality ChangePakistan
-
K.G. Razumovsky Moscow State University of Technologies...RecruitingStress | Stress (Psychology)Russia
-
Kansas State UniversityMGP Ingredients, Inc.WithdrawnOverweight or Obesity | Cholesterol, ElevatedUnited States
-
Duke UniversityCompletedTreatment and Prevention of Anemia After Administration of Gudness Nutrition BarIndia
-
Minia UniversityCompleted
-
Fayoum UniversityCompletedEdentulous Alveolar Ridge in MandibleEgypt
-
Al-Azhar UniversityActive, not recruitingDental Implant | Edentulous Alveolar Ridge | Implant Supported Overdenture | Complete Edentulism | Edentulous Jaw | Edentulous Mouth | AttachmentsEgypt
-
Hala Abdel salam SelimNot yet recruitingEdentulous Mandible | Implant-Supported OverdenturesEgypt
-
Rush University Medical CenterCures Within ReachCompletedPost Traumatic Stress DisorderUnited States